Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study

Michael R. Johnson | A. Uitterlinden | P. May | R. Krause | C. Reid | R. Balling | A. Palotie | P. Striano | A. Coppola | G. Avanzini | F. Dubeau | A. Marson | S. Sisodiya | S. Petrou | L. Carmant | H. Lerche | J. Sander | F. Rosenow | M. Ikram | J. Serratosa | M. Nothnagel | C. Depondt | G. Cavalleri | S. Schorge | F. Zara | A. Vignoli | H. Muhle | Y. Weber | I. Helbig | S. Franceschetti | N. Delanty | F. Zimprich | K. Jabbari | M. Nikanorova | H. Hjalgrim | J. V. van Rooij | R. Kraaij | K. Klein | P. Nürnberg | W. Jurkowski | M. Toliat | A. Gambardella | J. Altmüller | R. Nabbout | S. Girard | W. Kunz | P. Srivastava | G. Sills | C. D. de Kovel | C. Di Bonaventura | D. Nguyen | U. Ozbek | H. Thiele | P. Cossette | P. de Jonghe | D. Lal | Ann-Kathrin Ruppert | Anja C. M. Sonsma | T. Sander | G. Capovilla | F. Bisulli | A. Sirén | D. Trenité | E. Ferlazzo | N. Bebek | S. Maljevic | P. Tinuper | A. Lehesjoki | S. Cestèle | A. Lortie | S. Baulac | H. Caglayan | E. Leguern | C. Marini | S. Weckhuysen | A. La Neve | A. Avbersek | C. Leu | F. Becker | V. Belcastro | A. Bianchi | M. Iacomino | M. Arfan Ikram | C. D. Kovel | A. Jorgensen | B. Baykan | M. S. Vari | P. Jonghe | J. Schubert | M. Mccormack | D. Bobbili | P. Auce | J. Rooij | Kristin A Heggeli | A. Neve | C. Bonaventura | M. Mantegazza | R. S. Møller | B. Koeleman | M. Gravel | M. Krenn | C. Niturad | C. Meloche | B. Terragni | B. Francis | J. Sander | G. Crichiutti | R. Rusconi | R. Desbiens | Kate V. Everett | A. Polvi | C. Cieuta-Walti | Z. Yapıcı | R. Guerrero‐López | J. Willis | S. Wolking | Christian Hengsbach | S. Rau | J. Clément | S. Langley | B. Berghuis | M. Harrer | P. Lachance-Touchette | Julia Knaus | I.D. Coombs | Sarah Peter | D. Yalçın | G. Dizdarer | Kezban Arslan | D. Kuşçu | Merle Harrer | M. Vari | D. Trenite | Rikke S. Møller | A. Uitterlinden | Pamela Lachance-Touchette | M. A. Ikram | Dennis Lal | Anthony G. Marson | S. Sisodiya | A. Uitterlinden | Ben Francis | Wolfram S Kunz | A. G. Marson | Michael R. Johnson | Sarah R Langley | Micheline Gravel | Christopher A. Reid | B. Koeleman | Yvonne Weber | Dorothee G Kasteleijn-Nolst Trenite | Dang K. Nguyen | Bobby P. C. Koeleman

[1]  P. May,et al.  Exome-wide analysis of mutational burden in patients with typical and atypical Rolandic epilepsy , 2018, European Journal of Human Genetics.

[2]  François Dubeau,et al.  High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. , 2017, American journal of human genetics.

[3]  P. May,et al.  Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features , 2017, Brain : a journal of neurology.

[4]  O. Franco,et al.  The Rotterdam Study: 2018 update on objectives, design and main results , 2017, European Journal of Epidemiology.

[5]  Edouard Hirsch,et al.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.

[6]  Michael R. Johnson,et al.  Ultra-rare genetic variation in common epilepsies: a case-control sequencing study , 2017, The Lancet Neurology.

[7]  Ingo Borggraefe,et al.  Mutations in GABRB3: From febrile seizures to epileptic encephalopathies , 2017, Neurology.

[8]  Ethan M. Goldberg,et al.  De novo GABRG2 mutations associated with epileptic encephalopathies , 2017, Brain : a journal of neurology.

[9]  Joseph Watkins,et al.  A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy , 2016, Journal of Medical Genetics.

[10]  P. Striano,et al.  Phenotypic spectrum of GABRA1 , 2016, Neurology.

[11]  R. Macdonald,et al.  Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome. , 2016, JAMA neurology.

[12]  Xiaowei Zhan,et al.  RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data , 2016, Bioinform..

[13]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[14]  Tom R. Gaunt,et al.  The UK10K project identifies rare variants in health and disease , 2016 .

[15]  I. Scheffer,et al.  CHD2 variants are a risk factor for photosensitivity in epilepsy , 2015, Brain : a journal of neurology.

[16]  G. Lettre,et al.  Rare variant association studies: considerations, challenges and opportunities , 2015, Genome Medicine.

[17]  H. Beck,et al.  Impaired Action Potential Initiation in GABAergic Interneurons Causes Hyperexcitable Networks in an Epileptic Mouse Model Carrying a Human NaV1.1 Mutation , 2014, The Journal of Neuroscience.

[18]  A. Fatemi,et al.  A novel variant in GABRB2 associated with intellectual disability and epilepsy , 2014, American journal of medical genetics. Part A.

[19]  G. Abecasis,et al.  Rare-variant association analysis: study designs and statistical tests. , 2014, American journal of human genetics.

[20]  H. Mefford.  CNVs in Epilepsy , 2014, Current Genetic Medicine Reports.

[21]  P. Striano,et al.  Clinical dissection of early onset absence epilepsy in children and prognostic implications , 2013, Epilepsia.

[22]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[23]  D. Johnston,et al.  Ion channels in genetic and acquired forms of epilepsy , 2013, The Journal of physiology.

[24]  De novo mutations in epileptic encephalopathies , 2013 .

[25]  Kate M. Lawrence,et al.  Glucose transporter 1 deficiency in the idiopathic generalized epilepsies , 2012, Annals of neurology.

[26]  M. Rieder,et al.  Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.

[27]  K. Shianna,et al.  Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. , 2012, American journal of human genetics.

[28]  P. Striano,et al.  GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy , 2012, Neurology.

[29]  O. Franco,et al.  The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.

[30]  Caleb Davis,et al.  Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in Epilepsy , 2011, Cell.

[31]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[32]  Jing-Qiong Kang,et al.  Mutations in GABAA receptor subunits associated with genetic epilepsies , 2010, The Journal of physiology.

[33]  C. Baker,et al.  Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. , 2010, Brain : a journal of neurology.

[34]  I. Scheffer,et al.  Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. , 2009, Human molecular genetics.

[35]  Christian E Elger,et al.  15q13.3 microdeletions increase risk of idiopathic generalized epilepsy , 2009, Nature Genetics.

[36]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[37]  S. Leal,et al.  Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.

[38]  I. Módy,et al.  Altered Localization of GABAA Receptor Subunits on Dentate Granule Cell Dendrites Influences Tonic and Phasic Inhibition in a Mouse Model of Epilepsy , 2007, The Journal of Neuroscience.

[39]  H. Möhler,et al.  GABAA receptor diversity and pharmacology , 2006, Cell and Tissue Research.

[40]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[41]  B. Orser,et al.  Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-aminobutyric acid type A receptors , 2004 .

[42]  Wei-Yang Lu,et al.  Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy , 2002, Nature Genetics.

[43]  Michel Baulac,et al.  First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene , 2001, Nature Genetics.

[44]  David A. Williams,et al.  Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures , 2001, Nature Genetics.

[45]  S. Berkovic,et al.  Epilepsies in twins: Genetics of the major epilepsy syndromes , 1998, Annals of neurology.